{"title": "KOMBIGLYZE XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabetes Mellitu", "author": null, "url": "https://www.fiercepharma.com/pharma/kombiglyze%E2%84%A2-xr-saxagliptin-and-metformin-hcl-extended-release-tablets-a-new-treatment-for", "hostname": "fiercepharma.com", "description": "The first and only once-a-day metformin extended-release (XR) plus DPP-4 inhibitor combination tablet PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and | The first and only once-a-day metformin extended-release (XR) plus DPP-4 inhibitor combination tablet PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and", "sitename": "FiercePharma", "date": "2011-01-07", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}